Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City

Helena B Hansen, Carole E Siegel, Brady G Case, David N Bertollo, Danae DiRocco, Marc Galanter, Helena B Hansen, Carole E Siegel, Brady G Case, David N Bertollo, Danae DiRocco, Marc Galanter

Abstract

National data indicate that patients treated with buprenorphine for opiate use disorders are more likely to be White, highly educated, and to have greater incomes than those receiving methadone, but patterns of buprenorphine dissemination across demographic areas have not been documented in major metropolitan areas where poverty, minority populations and injection heroin use are concentrated. Rates of buprenorphine and methadone treatment are compared among areas of New York City defined by their income and ethnic/racial composition.

Residential social areas (hereinafter called social areas) were defined as aggregations of ZIP codes with similar race/ethnicity and income characteristics, and were formed based on clustering techniques. Treatment rates were obtained for each New York City ZIP code: buprenorphine treatment rates were based on the annual number of buprenorphine prescriptions written, and the methadone treatment rate on the number of methadone clinic visits for persons in each ZIP code. Treatment rates were correlated univariately with ethnicity and income characteristics of ZIP codes. Social area treatment rates were compared using individual ANOVA models for each rate.

Buprenorphine and methadone treatment rates were significantly correlated with the ethnicity and income characteristics of ZIP codes, and treatment rates differed significantly across the social areas. Buprenorphine treatment rates were highest in the social area with the highest income and lowest percentage of Black and Hispanic residents. Conversely, the methadone treatment rate was highest in the social area with the highest percentage of low income and Hispanic residents.

The uneven dissemination of 0pioid maintenance treatment in New York City may be reflective of the limited public health impact of buprenorphine in ethnic minority and low income areas. Specific policy and educational interventions to providers are needed to promote the use of buprenorphine for opiate use disorders in diverse populations.

Figures

Figure 1. Map or New York City…
Figure 1. Map or New York City Social Areas
Social area notations in parentheses indicate proportions of area residents who are impoverished, Black non-Hispanic, and Hispanic, respectively. L,M, and H denote low, medium, and high proportions, respectively. See text for definitions of social areas and treatment rates.

Source: PubMed

3
Abonnieren